Adherium Limited Stock

Equities

ADR

AU000000ADR1

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 01:21:41 2024-06-14 EDT 5-day change 1st Jan Change
0.016 AUD 0.00% Intraday chart for Adherium Limited -5.88% -71.43%

Financials

Sales 2022 529K 350K 480K Sales 2023 3.2M 2.11M 2.9M Capitalization 12.5M 8.27M 11.34M
Net income 2022 -10M -6.61M -9.08M Net income 2023 -9M -5.95M -8.17M EV / Sales 2022 19.4 x
Net cash position 2022 5.2M 3.44M 4.72M Net cash position 2023 9.03M 5.97M 8.2M EV / Sales 2023 1.08 x
P/E ratio 2022
-1.4 x
P/E ratio 2023
-1.04 x
Employees 40
Yield 2022 *
-
Yield 2023
-
Free-Float 83.99%
More Fundamentals * Assessed data
Dynamic Chart
1 week-5.88%
1 month-15.79%
3 months-60.98%
6 months-48.39%
Current year-71.43%
More quotes
1 week
0.02
Extreme 0.016
0.02
1 month
0.02
Extreme 0.015
0.03
Current year
0.02
Extreme 0.015
0.09
1 year
0.02
Extreme 0.015
0.09
3 years
0.02
Extreme 0.015
0.45
5 years
0.02
Extreme 0.015
0.96
10 years
0.02
Extreme 0.015
10.80
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 22-10-09
Chief Tech/Sci/R&D Officer - 20-08-02
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 74 15-04-16
Director/Board Member 61 15-12-16
Director/Board Member 66 15-07-19
More insiders
Date Price Change Volume
24-06-14 0.016 0.00% 1,300,337
24-06-13 0.016 -5.88% 50,000
24-06-12 0.017 0.00% 88,999
24-06-11 0.017 0.00% 313,668
24-06-07 0.017 +6.25% 100,429

Delayed Quote Australian S.E., June 14, 2024 at 01:21 am

More quotes
Adherium Limited is a New Zealand-based international respiratory e-health company. The Company is focused on patient medication adherence, remote monitoring and data management solutions for patients, payers and providers. The Company’s Hailie sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and chronic obstructive pulmonary disease (COPD), and reduces direct and indirect healthcare costs. The Company’s technologies include The Hailie Remote Patient Management (RPM) Solution, The Hailie Sensors and The Hailie Solution. Its Hailie solution is a cloud-based platform, which captures medication use data from Food and Drug Administration (FDA)-cleared Bluetooth enabled sensors, which wrap around patient inhalers and provide real-time feedback to patients via the Hailie application and to their physicians via the Hailie portal.
More about the company

Annual profits - Rate of surprise